Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Accumulated Expenses (2017 - 2019)

Updated

Takeda Pharmaceutical (TAK) posted Accumulated Expenses of $1.63 billion for the quarter ended Nov 29, 2019.

Analysis

Takeda Pharmaceutical (TAK) Accumulated Expenses (2017 - 2019) Analysis & Trends

As of Mar 31, 2019, Takeda Pharmaceutical's Accumulated Expenses came in at $1.37 billion.

  • In prior years, Takeda Pharmaceutical's Accumulated Expenses was $423.2 million in the year ended Dec 31, 2018 (+69.7%) and $249.4 million in the year ended Dec 31, 2017.
  • Quarterly Accumulated Expenses has run from a low of $423.2 million in the quarter ended Dec 31, 2018 to a high of $1.64 billion in the quarter ended Sep 30, 2019 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Takeda Pharmaceutical 2.59 Bn -23.92 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Nov 29, 2019 1.63 Bn
Sep 30, 2019 1.64 Bn
Jun 30, 2019 854.44 Mn
Mar 31, 2019 1.37 Bn
Dec 31, 2018 423.20 Mn
Mar 31, 2018 624.52 Mn
Dec 31, 2017 249.40 Mn
API Access

Takeda Pharmaceutical Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TAK&period=max&api_key=YOUR_API_KEY